🇺🇸 FDA
Pipeline program

GGTA1 KO Thymokidney

GPT-KF-101

Phase 2 mab active

Quick answer

GGTA1 KO Thymokidney for ESRD (End-Stage Renal Disease) is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
ESRD (End-Stage Renal Disease)
Phase
Phase 2
Modality
mab
Status
active

Clinical trials